It is the best of times; it is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference15 articles.
1. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis;Van der Heijde;Arthritis Rheum,2007
2. Combination therapy with methotrexate in severe rheumatoid arthritis;Tugwell;N Engl J Med,1995
3. The combination of leflunomide (LEF) and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who are failing on MTX treatment alone: a double-blind placebo (PLC) controlled study;Kremer;Arthritis Rheum,2000
4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate;Weinblatt;N Engl J Med,1999
5. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023;Annals of the Rheumatic Diseases;2023-10-30
2. Comparative effectiveness of biologic antirheumatic therapies in rheumatoid arthritis after failure to respond to a first TNF inhibitor;Journal of Comparative Effectiveness Research;2012-11
3. A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years;BMJ Open;2012
4. Comparative Effectiveness of Rheumatoid Arthritis Therapies;Current Rheumatology Reports;2010-07-23
5. B Cell Depletion in Early Rheumatoid Arthritis: A New Concept in Therapeutics;Annals of the New York Academy of Sciences;2009-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3